Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity

Heart and Lung: Journal of Acute and Critical Care

Volumn 38, Issue 1, 2009, Pages 48-55

  Yamakage, Michiaki ^a   Iwasaki, Sohshi ^a   Jeong, Seong Wook ^a   Satoh, Jun Ichi ^a   Namiki, Akiyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ESMOLOL; LANDIOLOL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OVALBUMIN; PROPRANOLOL; SHORT ACTING DRUG; STEROID; XANTHINE DERIVATIVE;

ADULT; AGED; AIRWAY HYPERREACTIVITY; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BOLUS INJECTION; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG SELECTIVITY; DRUG UTILIZATION; ENDOTRACHEAL INTUBATION; FEMALE; GUINEA PIG; HUMAN; IN VIVO STUDY; INTENSIVE CARE UNIT; LUNG COMPLIANCE; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; WHEEZING;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GUINEA PIGS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHOLINES; PROPANOLAMINES; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, BETA-1; RESPIRATORY SOUNDS; TREATMENT OUTCOME; UREA;

EID: 58149501126     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2008.01.002     Document Type: Article

References (49)

1. Hjalmarson A., Goldstein S., Fagerberg B., et al., MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA 283 (2000) 1295-1302
2. Heart Failure Society of America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches. Anonymous. Pharmacotherapy 20 (2000) 495-522
3. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28 (1996) 1328-1428
4. McMeill R.S. Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics. Lancet 13 (1964) 1101-1102
5. Raine J.M., Palazzo M.G., Kerr J.H., and Sleight P. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br J Med (Clin Res Ed) 282 (1981) 548-549
6. Williams I.P., and Millard F.J. Severe asthma after inadvertent ingestion of oxprenolol. Thorax 35 (1980) 160
7. Harries A.D. Beta-blockade in asthma. Br J Med (Clin Res Ed) 282 (1981) 1321
8. Fraunfelder F.T., and Barker A.F. Respiratory effects of timolol. N Engl J Med 311 (1984) 1441
9. Odeh M., Oliven A., and Bassan H. Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient. J Fam Pract 32 (1991) 97-98
10. Meeker D.P., and Wiedemann H.P. Drug-induced bronchospasm. Clin Chest Med 11 (1990) 165-175
11. August P. Initial treatment of hypertension. N Engl J Med 348 (2003) 610-617
12. Chen J., Radford M.J., Wang Y., Marciniak T.A., and Krumholz H.M. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 37 (2001) 1950-1956
13. Self T., Soberman J.E., Bubla J.M., and Chafin C.C. Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?. J Asthma 40 (2003) 839-845
14. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardiovascular beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 137 (2002) 715-725
15. Menkhaus P.G., Reves J.G., Kissin I., et al. Cardiovascular effects of esmolol in anesthetized humans. Anesth Analg 64 (1985) 327-334
16. Sheppard D., Distefano S., Byrd R.D., et al. Effects of esmolol on airway function in patients with asthma. J Clin Pharmacol 26 (1986) 169-174
17. Gold M.R., Dec G.W., Cocca-Spofford D., and Thompson B.T. Esmolol and ventilatory function in cardiac patients with COPD. Chest 100 (1991) 1215-1218
18. Iguchi S., Iwamura H., Nishizaki M., et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull 40 (1992) 1462-1469
19. Boskabady M.H., and Adel-Kardan S. Increased muscarinic receptor blockade by atropine in tracheal chains of ovalbumin-sensitized guinea pigs. Pharmacology 58 (1999) 300-308
20. Wu Z.-X., Zhou D., Chen G., and Lee L.-Y. Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea pigs. Am J Respir Crit Care Med 161 (2000) 73-80
21. Toward T.J., and Broadley K.J. Early and late bronchoconstrictions, airway hyperreactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin Exp Allergy 34 (2004) 91-102
22. Giles R.E., Finkel M.P., and Mazurowski J. Use of an analog on-line computer for the evaluation of pulmonary resistance and dynamic compliance in the anesthetized dog. Arch Int Pharmacodyn 194 (1971) 213-222
23. Hollenberg M., Mangano D.T., Browner W.S., London M.J., Tubau J.F., and Tateo I.M. Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 268 (1992) 205-209
24. 1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg 100 (2005) 733-737
25. Silvanus M.-T., Groeben H., and Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasms after tracheal intubation. Anesthesiology 100 (2004) 1052-1057
26. Murray J.F. History and physical examination. In: Murray J.F., and Nadel J.A. (Eds). Textbook of respiratory medicine (1989), Saunders, Philadelphia 443
27. Smith H. Animal models of asthma. Pulm Pharmacol 2 (1989) 59-74
28. Kodani M., Sakata N., Takano Y., et al. Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes. Immunopharmacol 49 (2000) 263-274
29. Abe M., Shibata K., Akatsu H., et al. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J Immunol 167 (2001) 4651-4660
30. Hershenson M.B., Aghili S., Punjabi N., et al. Hyperoxia-induced airway hyperresponsiveness and remodeling in immature rats. Am J Physiol 262 (1992) L263-L269
31. 1-selectivity and ultra-short duration of action. KISO TO EINSHO (written in Japanese) 31 (1997) 2913-2923
32. Iguchi S., Iwamura H., and Nishizaki M. Development of a highly cardioselective ultrashort-acting beta-blocker, ONO-1101. Chem Pharm Bull 40 (1992) 1462-1469
33. Emala C.W., Aryana A., and Hirshman C.A. Impaired activation of adenylyl cyclase in lung of the Besenji-greyhound model of airway hyperresponsiveness: decreased numbers of high affinity beta-adrenoceptors. Br J Pharmacol 118 (1996) 2009-2016
34. Emala C.W., Clancy-Keen J., and Hirshman C.A. Decreased adenylyl cyclase protein and function in airway smooth muscle by chronic carbachol pretreatment. Am J Physiol 279 (2000) C1008-C1015
35. Pizov R., Brown R.H., Weiss Y.S., et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology 82 (1995) 1111-1116
36. Volta C.A., Alvisi V., Petrini S., et al. The effect of volatile anesthetics on respiratory system resistance in patients with chronic obstructive pulmonary disease. Anesth Analg 100 (2005) 348-353
37. The Esmolol Research Group. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. Am Heart J 112 (1986) 498-505
38. Sasao J., Tarver S.D., Kindscher J.D., Taneyama C., Benson K.T., and Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth 48 (2001) 985-989
39. 1-blocking agent in healthy volunteers. RINSHO IYAKU (written in Japanese) 16 (2000) 1531-1556
40. Hasuo H., Tomiyasu S., and Hojo M. Effect of ONO-1101, a novel short-acting beta-blocker, on hemodynamic responses to isoflurane inhalation and tracheal intubation. J Anesth 12 (1998) 115-118
41. Kitamura A., Sakamoto A., Inoue T., and Ogawa R. Efficacy of an ultra-short-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur J Clin Pharmacol 51 (1997) 467-471
42. Fernandez-Galinski S., Bermejo S., Mansilla R., Pol O., and Puig M.M. Comparative assessment of the effects of alfentanil, esmolol or clonidine when used as adjuvants during induction of general anesthesia. Eur J Anaesthesiol 21 (2004) 476-482
43. Cheney F.W., Posner K.L., and Caplan R.A. Adverse respiratory events infrequently leading to malpractice suits. Anesthesiology 75 (1991) 932-939
44. Caplan R.A., Posner K.L., Ward R.J., and Cheney F.W. Adverse respiratory events in anesthesia. A closed claims analysis. Anesthesiology 72 (1990) 828-833
45. Warner D.O., Warner M.A., and Barnes R.D. Perioperative respiratory complications in patients with asthma. Anesthesiology 85 (1996) 460-467
46. Wajima Z., Yoshikawa T., and Ogura A. Intravenous colforsin daropate, a water-soluble forskolin derivative, prevents thiamylal-fentanyl-induced bronchoconstriction in humans. Crit Care Med 30 (2002) 820-826
47. 2-adrenergic receptor agonist and antagonist drugs on cholinergic contraction in bovine tracheal smooth muscle in vitro. Am J Vet Res 56 (1995) 930-935
48. 2-adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs. Anesthesiology 100 (2004) 359-363
49. 2-adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs. Anesthesiology 101 (2004) A1585